Financial Perspectives’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
1WCM
FCMI
Financial Perspectives's TXG Position: Q4 2021 in Review
Financial Perspectives sold out of 10x Genomics (TXG) in Q4 2021, closing a stake of 28 shares — an estimated $4.08K sold.
Financial Perspectives first reported a position in TXG in Q1 2021 and held it in 3 quarters. The position peaked at $28K in Q1 2021. 365 funds tracked by Wall St. Rank hold TXG as of Q4 2021.
- Financial Perspectives reported no remaining 10x Genomics position as of Q4 2021 after selling out during the quarter.
- Financial Perspectives sold 28 10x Genomics shares in Q4 2021, an estimated $4.08K.
- Financial Perspectives first reported a position in 10x Genomics in Q1 2021 and held it in 3 quarters.
- Financial Perspectives's 10x Genomics position peaked at $28K in Q1 2021.
- 365 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2021.
Based on Financial Perspectives's 13F filing for Q4 2021, filed 10 Jan 2024.